Therapeutic potential of human adipose-derived stem cells in neurological disorders

J Pharmacol Sci. 2014;126(4):293-301. doi: 10.1254/jphs.14R10CP. Epub 2014 Nov 18.

Abstract

Stem cell therapy has been noted as a novel strategy to various diseases including neurological disorders such as Alzheimer's disease, Parkinson's disease, stroke, amyotrophic lateral sclerosis, and Huntington's disease that have no effective treatment available to date. The adipose-derived stem cells (ASCs), mesenchymal stem cells (MSCs) isolated from adipose tissue, are well known for their pluripotency with the ability to differentiate into various types of cells and immuno-modulatory property. These biological features make ASCs a promising source for regenerative cell therapy in neurological disorders. Here we discuss the recent progress of regenerative therapies in various neurological disorders utilizing ASCs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipose Tissue / cytology*
  • Alzheimer Disease / therapy
  • Amyotrophic Lateral Sclerosis / therapy
  • Animals
  • Cell Differentiation
  • Cell- and Tissue-Based Therapy / methods*
  • Cell- and Tissue-Based Therapy / trends*
  • Humans
  • Huntington Disease / therapy
  • Mice
  • Nervous System Diseases / therapy*
  • Parkinson Disease / therapy
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / transplantation*
  • Regenerative Medicine / methods*
  • Regenerative Medicine / trends*
  • Stem Cell Transplantation / methods*
  • Stem Cell Transplantation / trends*